- Home
- DNB vs CORT Comparison
DNB vs CORT Comparison
Compare DNB & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNB
- CORT
- Stock Information
- Founded
- DNB 1841
- CORT 1998
- Country
- DNB United States
- CORT United States
- Employees
- DNB N/A
- CORT N/A
- Industry
- DNB Finance: Consumer Services
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- DNB Finance
- CORT Health Care
- Exchange
- DNB Nasdaq
- CORT Nasdaq
- Market Cap
- DNB 5.6B
- CORT 5.9B
- IPO Year
- DNB 2020
- CORT N/A
- Fundamental
- Price
- DNB $12.33
- CORT $53.63
- Analyst Decision
- DNB Buy
- CORT Strong Buy
- Analyst Count
- DNB 7
- CORT 4
- Target Price
- DNB $13.83
- CORT $75.25
- AVG Volume (30 Days)
- DNB 2.0M
- CORT 824.2K
- Earning Date
- DNB 02-13-2025
- CORT 02-13-2025
- Dividend Yield
- DNB 1.63%
- CORT N/A
- EPS Growth
- DNB N/A
- CORT 57.97
- EPS
- DNB N/A
- CORT 1.26
- Revenue
- DNB $2,380,200,000.00
- CORT $628,555,000.00
- Revenue This Year
- DNB $5.10
- CORT $46.29
- Revenue Next Year
- DNB $4.73
- CORT $17.09
- P/E Ratio
- DNB N/A
- CORT $42.54
- Revenue Growth
- DNB 4.46
- CORT 39.67
- 52 Week Low
- DNB $8.78
- CORT $20.84
- 52 Week High
- DNB $12.95
- CORT $62.22
- Technical
- Relative Strength Index (RSI)
- DNB 51.87
- CORT 46.46
- Support Level
- DNB $12.22
- CORT $49.51
- Resistance Level
- DNB $12.44
- CORT $60.90
- Average True Range (ATR)
- DNB 0.23
- CORT 2.69
- MACD
- DNB -0.04
- CORT -0.85
- Stochastic Oscillator
- DNB 46.15
- CORT 34.74
About DNB Dun & Bradstreet Holdings Inc.
Dun & Bradstreet Holdings Inc is a provider of business decisioning data and analytics. The company operates in two segments: North America, which offers Finance & Risk and Sales & Marketing data, analytics, and business insights in the United States and Canada; and International, which offers Finance & Risk and Sales & Marketing data, analytics, and business insights directly in the U.K, Europe, Greater China, India and indirectly through its WWN alliances. The company generates maximum revenue from the North American region. Other services provided by the company include digital marketing, sales acceleration, and risk management among others.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.